基线肠道微生物组和代谢物与随机Zonisamide临床试验参与者的酒精消费变化相关
Liv R Dedon1,2, Hanshu Yuan2, Jinhua Chi3
1Calhoun Cardiology Center, UConn School of Medicine, Farmington, CT, 06030, USA.
Scientific reports
|March 27, 2025
概括
基线肠道微生物组和GABA水平预测正在接受治疗的酒精使用障碍 (AUD) 患者的酒精消费减少. 这些发现可能会个性化干预措施,以获得更好的酒精减少结果.
科学领域:
- 微生物组研究的研究.
- 代谢学 代谢学 代谢学
- 神经科学是一个神经科学.
背景情况:
- 酒精使用障碍 (AUD) 与肠道微生物群变异有关.
- 肠道微生物在AUD治疗中的作用尚未完全理解.
研究的目的:
- 调查肠道微生物组在AUD治疗期间减少酒精消费中的作用.
- 为了确定治疗反应的潜在预测生物标志物.
主要方法:
- 从32名AUD参与者中收集了便样本,这些参与者正在接受zonizamide试验.
- 通过16S rRNA测序分析便微生物组和通过LC-MS.代谢组.
- 与饮用减少相关的微生物组合和代谢物.
主要成果:
- 基线微生物组组成与性和精神药物药物相关.
- 十一个属和整体微生物组结构与饮酒减少相关.
- 基线便GABA升高与饮酒减少正相关.
- 3-基氨酸与饮酒减少有负相关性,并且在低降低剂中更高.
结论:
- 基线肠道微生物组和GABA等特定代谢物对饮酒减少AUD很重要.
- 这些因素可以作为个性化AUD干预的预测工具.
- 进一步的研究可以优化减少酒精消费的治疗策略.
更多相关视频
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
9.5K
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
243
相关概念视频
CNS Depressants: Alcohol and Nicotine
1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Functions of the Gut Microbiota
233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233
Gut-Brain Axis
222
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
222
